Paul Burton
Chief Tech/Sci/R&D Officer chez AMGEN INC.
Fortune : 101 658 $ au 31/03/2024
Profil
Le Dr Paul Burton est responsable des affaires médicales mondiales chez Janssen Pharmaceuticals, Inc. Le Dr Burton était auparavant employé en tant que vice-président par Janssen Research & Development LLC. Il a obtenu un diplôme d'études supérieures de l'Université de Londres et un doctorat de l'Imperial College London.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MODERNA, INC.
0,00% | 07/11/2022 | 954 ( 0,00% ) | 101 658 $ | 31/03/2024 |
Postes actifs de Paul Burton
| Sociétés | Poste | Début |
|---|---|---|
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 01/06/2023 |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Chief Tech/Sci/R&D Officer | 01/03/2020 |
| Royal College of Surgeons | Corporate Officer/Principal | - |
Anciens postes connus de Paul Burton
| Sociétés | Poste | Fin |
|---|---|---|
| MODERNA, INC. | Chief Tech/Sci/R&D Officer | 01/01/2023 |
| JOHNSON & JOHNSON | Chief Tech/Sci/R&D Officer | - |
Janssen Research & Development LLC
 Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a private company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Corporate Officer/Principal | - |
Formation de Paul Burton
| Imperial College London | Doctorate Degree |
| University of London | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| MODERNA, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a private company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Commercial Services |
